UCLA State-of-the-Art Urology Conference - 47th Annual UCLA Department of Urology
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
UCLA Department of Urology
Presents
47th Annual
UCLA
State-of-the-Art
Urology
Conference
Friday- Sunday
March 4-6, 2022
The Ritz-Carlton
Marina del Rey, California
UCLA State-of-the-Art Urology
This course explores the most challenging management problems facing the practicing urologist.
Distinguished faculty present current information and techniques in urologic oncology (prostate, bladder,
kidney), male and female voiding dysfunction, incontinence, urinary tract infections, BPH surgical therapies,
neurogenic bladder, mini-perc for kidney stones, kidney stone prevention, disposable scopes, androgen
deficiency, prevention and management of penile prosthesis complications, prostate cancer focal and
radiation therapy, perineal prostate biopsy, active surveillance, genetic testing, advanced prostate cancer
therapy, robotic surgery, BCG refractory bladder cancer, upper tract TCCA, renal tumors, pediatric urology,
practice management, GU dermatology, and trauma. The conference emphasizes interaction between
participants and faculty and allows ample time for case presentations and group discussions, ensuring an
outstanding educational experience for attendees.
At the completion of this program, participants should be better able to:
• Utilize perineal biopsy for prostate cancer • Manage male and female voiding dysfunction
diagnosis and active surveillance • Utilize urethral bulking agents for incontinence
• Utilize molecular markers for personalizing • Apply the new guidelines for neurogenic bladder
prostate cancer care • Utilize mini-perc and ESWL for kidney stones
• Counsel patients on focal therapy for prostate • Prevent kidney stones
cancer • Utilize disposable scopes in urology
• Utilize PSMA imaging for managing patients with • Manage testosterone deficiency
prostate cancer • Prevent and treat penile prosthesis complications
• Improve quality of life in men on androgen • Understand the therapies for advanced prostate
deprivation therapy cancer and genetic testing
• Manage bladder cancer refractory to BCG • Manage recurrent UTI’s in women
• Manage patients with upper tract urothelial • Manage common pediatric urology problems
cancer • Manage dermatology problems in urology
• Manage the small renal mass • Apply new GU trauma guidelines
• Manage GU implications of menopause and • Determine the optimal surgical therapy for
hormone replacement therapy patients with BPH
A few days before the meeting you will be emailed a link and a password to download the individual
speaker handouts.
FACULTY
Guest Faculty Course Chair UCLA Faculty*
Laurence Klotz, CM, MD, FRCSC William J. Aronson, MD Albert J. Chang, MD, PhD
Professor of Surgery, University of Toronto Associate Professor
Sunnybrook Chair of Prostate Cancer Research Course Co-Chairs Director of Brachytherapy and Vice Chair of
Member, Order of Canada Craig Canfield, MD Surgical Services
Division of Urology Departments of Radiation Oncology and Urology
Karim Chamie, MD, MSHS
Sunnybrook Health Sciences Centre Jeremy Davis, MD, MS
Toronto, Ontario Department of Urology Faculty* Assistant Clinical Professor
Lori B. Lerner, MD Mark S. Litwin, MD, MPH Division of Dermatology
Associate Professor of Urology Professor and Chair Alexandra Drakaki, MD, PhD
Boston University School of Medicine Department of Urology Assistant Professor of Medicine and Urology
Chief, Section of Urology Professor of Health Policy and Management Director - Genitourinary Medical Oncology
Deputy Chief, Surgical Service School of Public Health Program
VA Boston Healthcare System Co-Director of Research, GU Trials Program
Boston, Massachusetts A. Lenore Ackerman, MD, PhD
Division of Hematology/Oncology and Institute of
James McKiernan, MD William J. Aronson, MD Urologic Oncology
John K. Lattimer Professor of Urology Z. Chad Baxter, MD
Amar U. Kishan, MD
Chairman, Department of Urology Karim Chamie, MD, MSHS Associate Professor
New York, New York Arnold I. Chin, MD, PhD Chief of Genitourinary Oncology Service
Manoj Monga, MD, FACS, FRCS Matthew Dunn, MD Vice Chair of Clinical and Translational Research
Professor and Chair Sriram Eleswarapu, MD, PhD Department of Radiation Oncology
Department of Urology Kiran Gollapudi, MD Sandy T. Liu, MD
University of California San Diego Assistant Professor
San Diego, California Ja-Hong Kim, MD
Division of Hematology-Oncology, Department
Steven E. Lerman, MD
Mark N. Painter, BA, CPMA of Medicine
CEO Leonard S. Marks, MD Institute of Urologic Oncology, Department of
PRS Managed Services, LLC Jesse N. Mills, MD Urology
Denver, Colorado Victor W. Nitti, MD Matthew Rettig, MD
Ranjith Ramasamy, MD Allan J. Pantuck, MD, MS Professor of Medicine and Urology
Director of Reproductive Urology Jacob Rajfer, MD Medical Director, Prostate Cancer Program
Associate Professor Robert E. Reiter, MD, MBA Institute of Urologic Oncology
University of Miami Associate Director, Hematology-Oncology
Christopher S. Saigal, MD, MPH
Miami, Florida Fellowship Program
Kymora Scotland, MD, PhD Chief, Division of Hematology-Oncology
Nirit Rosenblum, MD
Joseph D. Shirk, MD VA Greater Los Angeles – West Los Angeles
Associate Professor of Urology and Obstetrics
and Gynecology Brian Shuch, MD
*David Geffen School of Medicine at UCLA
Division of FPMRS Jennifer S. Singer, MD
Department of Urology Renea Sturm, MD
NYU Langone Medical Center
New York, New York
G E N E R A L I N F O R M A T I O N
Enrollment Fees Accommodations
(Fees include course registration and materials, daily A block of rooms has been reserved at the Ritz-Carlton for
continental breakfasts and breaks, Friday evening conference participants at a special conference rate of
reception, and Friday and Saturday luncheons.) $324 plus tax per night for single/double occupancy. One
$550.00 Physicians night’s deposit is required to guarantee late arrival (after
$350.00 David Geffen School of Medicine at UCLA 5pm). Confirmation of reservations received after February
Faculty* 17, 2022 is subject to availability.
$275.00 Non-Physician, Healthcare Professionals For reservations call 310-823-1700 or 800-241-3333.
$110.00 Residents (accompanied by a confirmatory Be sure to mention UCLA’s State-of-the-Art Urology
letter of status from department chief or Conference when calling in your reservations.
training director) Valet Parking
*Please indicate faculty appointment title and campus on Daytime: $20
registration form. Overnight: $30
Refunds Accreditation
Cancellations must be received in writing by January 31, The Office of Continuing Medical Education, David
2022, and will be subject to a $75 processing fee. No Geffen School of Medicine at UCLA is accredited by the
refunds will be given after that date. If, for any reason, the Accreditation Council for Continuing Medical Education to
course must be canceled, discontinued, or rescheduled by provide continuing medical education for physicians.
the Office of Continuing Medical Education, a full refund
The Office of Continuing Medical Education, David Geffen
will be provided.
School of Medicine at UCLA designates this live activity
If the in-person gathering is canceled or capacity limits for a maximum of 21.5 AMA PRA Category 1 CreditsTM.
are modified per CDC or public health guidelines, the Physicians should claim only the credit commensurate
conference will be modified accordingly. with the extent of their participation in the activity.
The California State Board of Registered Nursing accepts
COVID Protocols & Policies
courses approved by the AMA for category 1 credit
At the present time, UCLA policy mandates that all as meeting the continuing education requirements for
in-person participants for any UCLA meeting on and off license renewal. Nurses from states other than California
campus comply with the following to attend the event: should inquire with their local State Board for specific
• Proof of vaccination OR proof of a negative COVID-19 continuing education policies.
test within 72 hours of beginning of the event
American Society of Radiologic Technologists Credit
• Wear masks at all times, except when actively eating
Category A/A+ CE credit is pending approval by the ASRT.
or drinking, regardless of vaccination status
Disclosure
The following are acceptable as proof of negative
COVID-19 test result from a PCR or antigen test: The FDA has issued a concept paper that classifies
the commercial support of scientific and educational
a) A printed document from the test provider or
programs as promotional unless it can be affirmed
laboratory, OR
that the program is “truly independent” and free of
b) An electronic test result displayed on a phone or other commercial influence. Along with independence, the FDA
device from the test provider or laboratory which requires that non-promotional, commercially supported
should include person’s name, type of test performed, education be objective, balanced, and scientifically
and negative test result rigorous. The policy further states that all potential
Participants who are not compliant with the UCLA COVID conflicts of interest of the CME staff and faculty be fully
policy will not be permitted to attend the event in-person. disclosed to the program’s participants. In addition,
We will provide additional details regarding the process Accreditation Council for Continuing Medical Education
for submitting proof of vaccination or negative test result, policy mandates that the sponsor adequately manage
in advance or onsite, prior to the course. all identified potential conflicts of interest prior to the
program. We at UCLA fully endorse the letter and spirit of
Location these concepts.
The Ritz-Carlton, Marina del Rey The Department of Urology is a California Board of
4375 Admiralty Way Nursing approved provider (#8888).
Marina del Rey, California 90292
310-823-1700 or 800-241-3333
310-823-2404 facsimile
www.ritzcarlton.com/hotels/marina_del_rey
Please visit our websites: www.uclaurology.com and www.cme.ucla.edu
Follow us on social media: #UCLAUrology and #UCLASOTAF R I D A Y , M A R C H 4 , 2 0 2 2
M O RN ING AFTE RN OON
7:00 EGISTRATION/BREAKFAST/
R Urolithiasis/Endourology
EXHIBITS
7:55 Introductions and Announcements Moderator: Matthew Dunn, MD
William J. Aronson, MD 1:00 hock Wave Lithotripsy – The Beat
S
Goes On
Male and Female Voiding Dysfunction,
Reconstruction, Estrogen Replacement
Manoj Monga, MD, FACS, FRCS
Therapy 1:15 T he Mini-Perc – Indications and
Technique
Moderator: Victor W. Nitti, MD Matthew Dunn, MD
8:00 ecurrent UTI’s: Evaluation and
R 1:30 How to Prevent a Kidney Stone
Management of a Common Problem Manoj Monga, MD, FACS, FRCS
Nirit Rosenblum, MD
1:45 ideo – Ureteroscopy for an
V
8:15 rethral Bulking for Female SUI –
U Impacted Stone – Tips and Tricks
State of the Art 2022 Manoj Monga, MD, FACS, FRCS
Victor W. Nitti, MD
2:00 anel Discussion – Audience
P
8:30 U implications of Menopause and
G Questions – Case Presentations
Hormone Replacement Therapy
Nirit Rosenblum, MD
Including Use of Disposable Scopes
Moderator: Dr. Matthew Dunn
8:45 lassifying Patients with Pelvic
C Panel: Drs. Monga and Scotland
Pain to Guide Treatment Decisions
A. Lenore Ackerman, MD, PhD 3:00 BREAK/EXHIBITS
8:55 anel Discussion: Common
P Men’s Health – Testosterone Deficiency,
Problems in Female Pelvic Complex Penile Prosthesis
Medicine
Moderator: Jesse N. Mills, MD
Audience Questions – Case
Presentations 3:20 T estosterone Deficiency and
Moderator: Dr. Victor W. Nitti Treatment
Panel: Drs. Ackerman, Baxter, Kim, Ranjith Ramasamy, MD
and Rosenblum
3:40 E ndocrine Disruptors and Sexual
9:50 BREAK/EXHIBITS Health: What Urologists Should
Know
10:10 ptimizing BPH Surgical Therapy in
O
Sriram Eleswarapu, MD, PhD
2022 – Morphology Matters
Lori B. Lerner, MD 3:55 enile Prosthesis – A Step by Step
P
Approach
10:40 eurogenic Lower Urinary Tract
N
Dysfunction
Prevention of Complications
Applying the New Guidelines Ranjith Ramasamy, MD
Victor W. Nitti, MD
4:15 alvaging Penile Prosthesis
S
11:00 anel Discussion: Common
P Complications
Problems in Male Voiding Jesse N. Mills, MD
Dysfunction
Audience Questions – Case 4:35 anel Discussion – Audience
P
Presentations Questions – Case Presentations
Moderator: Dr. Victor W. Nitti Moderator: Dr. Jesse N. Mills
Panel: Drs. Baxter, Kim, and Lerner Panel: Drs. Eleswarapu, Rajfer, and
Ramasamy
12:00 LUNCH
5:45 ADJOURN/RECEPTIONS A T U R D A Y , M A R C H 5 , 2 0 2 2
M ORN IN G AFTERN OON
6:30 BREAKFAST/EXHIBITS Bladder Cancer
V I D E O S E S S I O N
Moderator: Mark S. Litwin, MD, MPH
7:00 T ransitioning From Multiport to 1:00 T reatment of Non-Muscle Invasive
Single Port Robotic Surgery Bladder Cancer in the Modern Era
Focus on Retroperitoneal Radical James McKiernan, MD
Prostatectomy 1:20 dvances in Upper Tract Urothelial
A
Arnold I. Chin, MD, PhD Cancer
7:30 obotic Radical Prostatectomy –
R Karim Chamie, MD, MSHS
Maximizing Continence, Potency, 1:40 CG Unresponsive Bladder Cancer:
B
Negative Margins Where Are We Now and Where Are
Robert E. Reiter, MD, MBA We Going
James McKiernan, MD
Prostate Cancer
2:00 anel Discussion and Case
P
Moderator: Mark S. Litwin, MD, MPH Presentations
8:00 tate of the Art - Imaging and
S Moderator: Dr. Mark S. Litwin
Biomarkers for Diagnosis and Panel: Drs. Chamie, Chang, Chin,
Active Surveillance Drakaki, and McKiernan
erineal Biopsy, Micro-Ultrasound,
P 2:50 BREAK/EXHIBITS
Liquid Biopsies, and More
Laurence Klotz, CM, MD, FRCSC Kidney Cancer
8:30 adiotherapy for Primary Treatment
R Moderator: Brian Shuch, MD
and Biochemical Recurrence in
3:10 Improving Risk Stratification of the
2022
Renal Mass in Urologic Practice
Amar U. Kishan, MD
Brian Shuch, MD
8:45 Focal Therapy – Uses and Misuses
3:25 ideo – Improving Partial
V
Laurence Klotz, CM, MD, FRCSC Nephrectomy with 3-D Imaging
9:05 anel Discussion – Audience
P Guidance
Questions – Case Presentations Joseph D. Shirk, MD
Moderator: Dr. Mark S. Litwin 3:45 djuvant Therapy – A Paradigm
A
Panel: Drs. Kishan, Klotz, Marks, Shift for Urological Management
and Reiter Brian Shuch, MD
10:00 BREAK/EXHIBITS 3:55 anel Discussion and Case
P
10:20 Improving Survival and Quality of Presentations
Life in Men on ADT Moderator: Dr. Brian Shuch
Laurence Klotz, CM, MD, FRCSC Panel: Drs. Chamie, Liu, Pantuck,
and Shirk
10:40 etastasis Directed Therapy in the
M
Era of PSMA Imaging 5:00 ADJOURN
Robert E. Reiter, MD, MBA
10:55 T herapy for Advanced Prostate
Cancer in 2022
What the Urologist Needs to Know
Matthew Rettig, MD
11:10 anel Discussion – Audience
P
Questions – Case Presentations
Moderator: Dr. Mark S. Litwin
Panel: Drs. Kishan, Klotz, Marks,
Rettig, and Reiter
12:00 LUNCHS U N D A Y , M A R C H 6 , 2 0 2 2
M ORN IN G GU Dermatology and Trauma
6:30 BREAKFAST/EXHIBITS
Moderator: William J. Aronson, MD
V I D E O S E S S I O N
10:20 GU Dermatology – Practical Aspects
7:00 Endourology Tips and Tricks Jeremy Davis, MD, MS
The Mini-Perc, and More 10:45 enitourinary Trauma – The Latest
G
Matthew Dunn, MD Guidelines
Kiran Gollapudi, MD
Practice Management
Pediatric Urology
Moderator: Christopher S. Saigal, MD, MPH
8:00 Practice Management Moderator: Steven E. Lerman, MD
• Medicare and E/M Update 2022 11:10 What’s New in Pediatric Urology
Steven E. Lerman, MD, Jennifer S.
• Appropriate Use of Telehealth in Singer, MD, and Renea Sturm, MD
Urology
11:40 ediatric Urology Panel Discussion
P
• Modifiers and Documentation - and Case Presentations
Scenario Based Coding Session Moderator: Dr. Steven E. Lerman
Mark N. Painter, BA, CPMA Panel: Drs. Singer and Sturm
10:00 BREAK/EXHIBITS 12:30 ADJOURN
View from the Ritz-Carlton, Marina del ReyEnrollment By FAX
Send the completed enrollment form with charge card
Online information and authorizing signature to the Office of
Use your American Express, MasterCard, Visa, or Continuing Medical Education at 310-794-2624.
Discover card.
www.cme.ucla.edu/courses ENROLLMENT IS LIMITED.
Click on “UCLA State-of-the-Art Urology.” EARLY ENROLLMENT IS ADVISED.
By Mail For additional information, contact the Office of Continuing
Use the attached form. For additional applications, use Medical Education, David Geffen School of Medicine at
a photocopy or separate sheet giving all information UCLA, Urology Conference, 10920 Wilshire Boulevard,
requested on the form. Suite 1060, Los Angeles, CA 90024-6512; 310-794-2620;
By Phone E-Mail address: uclacme@mednet.ucla.edu.
Use American Express, MasterCard, Visa, or Discover.
Call 310-794-2620.
"
R EGI S TR ATI ON F ORM
Winter 2022
Fee General Session Fee
$550.00 Physicians
UCLA State-of-the-Art Urology M212-24 $
$350.00 David Geffen School of Medicine at UCLA
Total $ Faculty
$275.00 Non-Physicians, Healthcare Professionals
$110.00 Residents (accompanied by a confirmatory
Please Print letter of status from department chief or
training director)
Social Security Number (last four digits only)
Name (First/Middle/Last) Degree (MD, PhD, RN, NP, etc.)
Preferred Mailing Address
City/State/ZIP
Area Code/Daytime Phone Fax
E-mail address (REQUIRED)
Field of Practice
If UCLA faculty, indicate:______________________________________________ ____________________________
Faculty Appointment Title Campus
Some of the exhibitors would like to get in touch with course attendees following the meeting. May we share your name
and email address with the exhibitors?
q Y es q N
o
q Check enclosed payable to: The Regents of the University of California
Charge: q American Express q MasterCard q Visa q Discover
__________________________ – __________________________ – __________________________ – �����������
Card Number
Authorizing Signature Expiration Date
Mail to: Office of Continuing Medical Education, Urology, David Geffen School of Medicine at UCLA,
10920 Wilshire Blvd., Suite 1060, Los Angeles, CA 90024-6512.
Fax to: 310-794-2624UCLA Office of Continuing Medical Education David Geffen School of Medicine at UCLA MC29 405 Hilgard Avenue Box 956938 Los Angeles, CA 90095-6938 UCLA Department of Urology UCLA State-of-the-Art Urology March 4-6, 2022 The Ritz-Carlton Marina del Rey, California
You can also read
